$OKUR
OnKure Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.96
▲+2.78%+$0.080
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOnKure Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is OKUR up today? It is at $2.96 (+2.78%). See the catalyst behind the move, real-time alerts the moment OKUR spikes, and full due diligence on OKUR — key stats, earnings, dilution and insider activity. Free.
Be first to know when $OKUR makes an unusual move. Create a free account to track $OKUR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OKUR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OKUR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Leverone Jason A. Officer | Sold (automatic/other) | -303 | sold 1.6% | 19K | $1K at $4.40 | Jun 22, 26 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -86 | sold 0.8% | 11K | $378 at $4.40 | Jun 22, 26 |
Leverone Jason A. Officer | Sold (automatic/other) | -301 | sold 1.8% | 16K | $1K at $4.16 | Mar 23, 26 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -86 | sold 1.2% | 7K | $358 at $4.16 | Mar 23, 26 |
Manke Isaac Director | Acquired (grant/award) | +5K 0.01% of company | added 34% | 21K | n/a | Dec 31, 25 |
Mathers Edward T Director | Acquired (grant/award) | +4K | added 34% | 15K | n/a | Dec 31, 25 |
Leverone Jason A. Officer | Sold (automatic/other) | -302 | sold 1.8% | 16K | $897 at $2.97 | Dec 22, 25 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -87 | sold 1.2% | 7K | $258 at $2.97 | Dec 22, 25 |
Manke Isaac Director | Acquired (grant/award) | +6K 0.01% of company | added 57% | 15K | n/a | Sep 30, 25 |
Mathers Edward T Director | Acquired (grant/award) | +4K 0.01% of company | added 57% | 11K | n/a | Sep 30, 25 |
Leverone Jason A. Officer | Sold (automatic/other) | -303 | sold 2.3% | 13K | $794 at $2.62 | Sep 22, 25 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -88 | sold 2.4% | 4K | $231 at $2.62 | Sep 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on OKUR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OKUR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
OKUR last traded at $2.96, up 2.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The OKUR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OKUR 0 times in the last 30 days.
OKUR (OnKure Therapeutics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $117M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OKUR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OKUR discussion
Sign in to ask a question or join the discussion.